Thr 163 Phosphorylation Causes Mcl-1 Stabilization when Degradation Is Independent of the Adjacent GSK3-Targeted Phosphodegron, Promoting Drug Resistance in Cancer

• Shanna K. Nifoussi ,

  Contributed equally to this work with: Shanna K. Nifoussi, Julie A. Vrana

  Affiliations Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States of America

  ⨯
• Julie A. Vrana ,

  Contributed equally to this work with: Shanna K. Nifoussi, Julie A. Vrana

  Current address: Immunostains Laboratory, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Aaron M. Domina,
• Alfredo De Biasio,
• Jingang Gui,
• Mark A. Gregory,
• Stephen R. Hann,

  Affiliation Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America

  ⨯
• Ruth W. Craig

  * E-mail: Ruth.W.Craig@Dartmouth.edu

  Affiliations Department of Pharmacology and Toxicology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States of America, Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States of America

  ⨯